Diagnostic Testing

Topic Overview

Diagnostic testing forms a critical component of clinical decision-making for the Family Nurse Practitioner. Selecting the appropriate test, interpreting results accurately, and understanding test limitations directly impact patient outcomes and safety. For exam purposes, you must not only know which test to order for a given presentation but also understand sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and factors that influence results.

Why this matters: Board exams emphasize test selection based on pretest probability, disease prevalence, and patient characteristics. Mastery of diagnostic reasoning reduces unnecessary testing and improves diagnostic accuracy.

Key Concepts and Definitions

• Sensitivity: The ability of a test to correctly identify those with the disease (true positive rate). A highly sensitive test is best used to rule out disease (SnOUT).
• Specificity: The ability of a test to correctly identify those without the disease (true negative rate). A highly specific test is best used to rule in disease (SpIN).
• Positive Predictive Value (PPV): The probability that a person with a positive test result actually has the disease. PPV increases with disease prevalence.
• Negative Predictive Value (NPV): The probability that a person with a negative test result truly does not have the disease. NPV decreases as disease prevalence rises.
• Pretest Probability: The estimated likelihood of disease before testing, based on history, physical exam, and population risk factors.
• Likelihood Ratio (LR): Combines sensitivity and specificity to determine how much a test result changes the probability of disease. LR+ > 10 strongly suggests disease; LR− < 0.1 strongly rules out disease.
• Accuracy: The overall proportion of correct results (true positives + true negatives) among all results.
• Reference Range: The range of test values expected in a healthy population. Always interpret with patient context, not as absolute cutoff.

Core Principles of Diagnostic Test Selection

1. Establishing the Purpose of Testing

• Screening: Applied to asymptomatic populations to detect early disease (e.g., mammography, colonoscopy, lipid panel). High sensitivity is prioritised.
• Diagnosis: Confirms or excludes a suspected condition based on symptoms and exam findings. Both sensitivity and specificity matter.
• Monitoring: Tracks disease progression or treatment response (e.g., HbA1c in diabetes, INR on warfarin).
• Prognosis: Provides information about likely disease course or outcome (e.g., BNP in heart failure).

2. Evaluating Test Performance Using a 2x2 Table

1. Identify true positives (TP): diseased individuals with a positive test.
2. Identify false positives (FP): non-diseased individuals with a positive test.
3. Identify true negatives (TN): non-diseased individuals with a negative test.
4. Identify false negatives (FN): diseased individuals with a negative test.
5. Calculate sensitivity = TP ÷ (TP + FN).
6. Calculate specificity = TN ÷ (TN + FP).
7. Calculate PPV = TP ÷ (TP + FP).
8. Calculate NPV = TN ÷ (TN + FN).

Exam tip: You will not be asked to compute these on most board exams, but you must understand how prevalence impacts PPV and NPV. As prevalence decreases, PPV decreases and NPV increases.

3. Understanding Bayes' Theorem in Practice

• Pretest probability is adjusted based on test results to produce posttest probability.
• A positive result on a highly specific test (SpIN) significantly increases posttest probability.
• A negative result on a highly sensitive test (SnOUT) significantly decreases posttest probability.
• Serial testing (multiple tests in sequence) is used when high certainty is needed and each test is independent.

Common Diagnostic Tests by System — High-Yield for FNP

Cardiovascular

• ECG: First-line for chest pain, palpitations, syncope. Look for ST-elevation MI, ischemia, arrhythmias, and chamber hypertrophy.
• Echocardiogram: Assesses ejection fraction, wall motion, valvular function, and pericardial effusion.
• Stress Testing: Exercise or pharmacologic (dobutamine, adenosine). Used for ischemic evaluation. Contraindications: acute MI, unstable angina, uncontrolled arrhythmia.
• BNP/NT-proBNP: Elevated in heart failure. High sensitivity for ruling out heart failure in dyspneic patients.
• Troponin: Cardiac-specific. Elevated in MI, myocarditis, and severe demand ischemia. Appears 2–4 hours after onset, peaks at 12–24 hours.

Pulmonary

• Chest X-ray (CXR): PA and lateral views. First-line for cough, dyspnea, chest pain, suspected pneumonia, pneumothorax, or effusion.
• CT Chest: Higher resolution. Used when CXR is inconclusive or when pulmonary embolism (PE), interstitial lung disease, or malignancy is suspected.
• Pulmonary Function Tests (PFTs): FEV1/FVC ratio distinguishes obstructive (ratio < 0.7) from restrictive (ratio normal or increased with low TLC).
• D-Dimer: Highly sensitive but nonspecific. Used to rule out venous thromboembolism (DVT/PE) when clinical probability is low or moderate. Elevated in pregnancy, infection, cancer, and post-surgery.
• ABG: Assesses oxygenation, ventilation, and acid-base status. Indicate when pulse oximetry is unreliable or respiratory failure is suspected.

Gastrointestinal & Hepatobiliary

• Complete Blood Count (CBC): Anemia workup, infection, bleeding. MCV helps classify anemia (microcytic, normocytic, macrocytic).
• Basic Metabolic Panel (BMP): Renal function (BUN, creatinine, GFR), electrolytes, glucose. Essential in hypertension, diabetes, and before contrast imaging.
• Liver Panel: ALT, AST, alkaline phosphatase, bilirubin, GGT. Pattern recognition: hepatocellular injury (ALT > AST), cholestatic (ALP & GGT elevated).
• Lipase: Highly specific for acute pancreatitis. Order when epigastric pain radiates to back. Amylase is less specific.
• Abdominal Ultrasound: First-line for RUQ pain (gallstones, cholecystitis), abdominal aortic aneurysm screening, and renal colic evaluation.
• Colonoscopy: Gold standard for colorectal cancer screening. Prep quality and adequate withdrawal time matter. Contraindications: acute diverticulitis, recent MI, severe coagulopathy.

Endocrine & Metabolic

• Hemoglobin A1c: Reflects average glucose over 2–3 months. Diagnostic thresholds: normal < 5.7%, prediabetes 5.7–6.4%, diabetes ≥ 6.5%. Limitations: inaccurate in anemia, hemoglobinopathies, and chronic kidney disease.
• Fasting Glucose: Normal < 100 mg/dL, impaired fasting glucose 100–125 mg/dL, diabetes ≥ 126 mg/dL on two occasions.
• OGTT (Oral Glucose Tolerance Test): Used in gestational diabetes and when diabetes is suspected but fasting glucose is equivocal. 2-hour value ≥ 200 mg/dL indicates diabetes.
• TSH: First-line screening for thyroid dysfunction. If abnormal, follow with free T4 and T3.
• Cortisol / ACTH: For adrenal insufficiency or Cushing's syndrome. Cosyntropin stimulation test is diagnostic for adrenal insufficiency.

Renal & Urinary

• Urinalysis (UA): Dipstick for glucose, ketones, blood, protein, leukocyte esterase, nitrites. Microscopy for casts, crystals, RBCs, WBCs. Key findings: WBC casts suggest pyelonephritis; RBC casts suggest glomerulonephritis.
• Urine Culture: Confirms UTI when UA is positive. Growth of ≥ 10⁵ CFU/mL of a single organism is diagnostic.
• BUN/Creatinine Ratio: Normal ~10:1. Elevated ratio (> 20:1) suggests prerenal causes (dehydration, heart failure). Normal or low ratio suggests intrinsic renal or postrenal causes.
• eGFR: Calculated from creatinine, age, sex, and race (CKD-EPI or MDRD). Used to stage chronic kidney disease: Stage 3 = eGFR 30–59 mL/min/1.73 m².
• Renal Ultrasound: Evaluates for hydronephrosis, stones, cysts, masses, and renal size. First-line imaging for AKI if obstruction is suspected.

Infectious Disease

• White Blood Cell (WBC) Count: Elevated in bacterial infection; may be normal or low in viral or atypical infections.
• C-Reactive Protein (CRP): Acute-phase reactant. Nonspecific but useful for monitoring inflammatory response and treatment efficacy.
• Procalcitonin: More specific than CRP for bacterial infection. Helps guide antibiotic therapy decisions. < 0.25 ng/mL suggests low risk of bacterial infection.
• Lyme Serology: Two-tier testing: ELISA followed by Western blot if positive. IgM appears early (first 4 weeks); IgG persists.
• HIV Testing: Fourth-generation tests detect p24 antigen and HIV-1/2 antibodies. Window period: 2–4 weeks for antigen, up to 3 months for antibody-only tests.
• Influenza, RSV, COVID-19: PCR is gold standard. Rapid antigen tests have lower sensitivity (higher false negatives) but faster turnaround.

Interpreting Common Lab Abnormalities

Imaging Modalities — When to Choose What

• Plain Radiograph (X-ray): Best for bony structures, air-fluid levels, and basic chest pathology. Low radiation, widely available, low cost.
• Ultrasound: No radiation. Best for soft tissue, fluid collections, gallbladder, renal, pelvic, and vascular assessment. Operator-dependent.
• CT Scan: Excellent for anatomic detail. Used in trauma, acute abdomen, PE (CT angiogram), and cancer staging. Contrast considerations: caution in renal impairment (check eGFR > 30 for IV contrast) and metformin use (hold after contrast if eGFR < 30).
• MRI: Superior for soft tissue, brain, spinal cord, joints, and pelvic pathology. No ionizing radiation. Contraindications: certain metallic implants, pacemakers (unless MRI-compatible), severe claustrophobia.
• Nuclear Imaging (PET, V/Q): Functional imaging. PET used for oncology and inflammation; V/Q for PE when CT is contraindicated or when young female patient (lower radiation to breast tissue).

Safety Precautions and Common Pitfalls

• Contrast-induced nephropathy (CIN): Risk increases with eGFR < 45, diabetes, dehydration, and high contrast volume. Prevention: IV fluids (normal saline or bicarbonate) before and after contrast; hold nephrotoxic medications.
• False positives and false negatives: Always consider test limitations. A positive result in a low-prevalence population is more likely to be false positive than true positive.
• Incidental findings: Thyroid nodules, adrenal masses, pulmonary nodules—do not ignore, but avoid over-investigation without clinical context.
• Panic values / critical results: Hypokalemia (< 2.5 mEq/L), hyperkalemia (> 6.0 mEq/L), platelet count < 20K, hemoglobin < 6 g/dL, INR > 5.0. Must recheck value, notify patient or caretaker, and intervene immediately.
• Medication interference: Biotin supplements interfere with thyroid tests and troponin assays. Psychotropic medications can cause false-positive urine drug screens. Antipsychotics may elevate prolactin.
• Informed consent: Required for invasive procedures (endoscopy, biopsy, contrast with known risk). Ensure patient understands purpose, risks, benefits, and alternatives.

Exam Tips and High-Yield Points

• Remember SnOUT and SpIN: Sensitive test when negative rules OUT; Specific test when positive rules IN.
• For a high pre-test probability, even a negative test does not fully rule out disease—continue working up.
• For a low pre-test probability, a positive test is frequently a false positive—confirm with a second test.
• Screening tests (e.g., mammography, Pap smear, colonoscopy) are designed for high sensitivity; they sacrifice some specificity to avoid missing disease.
• Confirmatory tests (e.g., biopsy, angiography, echocardiogram) are designed for high specificity to avoid misdiagnosis.
• Common board favorite: D-dimer is useful to rule out DVT/PE only in low or moderate clinical probability. Never use it to rule in disease.
• Procalcitonin is increasingly tested as a guide for antibiotic stewardship—less than 0.25 ng/mL suggests no bacterial infection.
• Urine pregnancy test must be obtained before any imaging involving radiation in all women of childbearing potential.
• Learn the patterns: Microcytic anemia → iron studies; normocytic anemia → reticulocyte count and hemolysis labs; macrocytic anemia → B12 and folate.
• For acute chest pain: ECG immediately, then troponin. Negative serial troponins with normal ECG do not rule out unstable angina—further risk stratification is needed.
• For acute dyspnea: BNP (rule out heart failure) and CXR (rule out pneumonia, effusion, or pneumothorax) are first-line.
• Always check medication list before ordering tests—common drugs alter lab values (e.g., diuretics cause hypokalemia, ACEi elevate creatinine, metformin and contrast risk).

Quick Review Table: Common Test Indications